TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01853930

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Platform for Administering Eye-movement Control Training
Description: The Platform for Administering Eye-movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Platform for Administering Eye-movement Control Training
Description: The Platform for Administering Eye-movement Control Training (PAECT) meta program will incorporate all of the exercises that the investigators have developed and validated over the course of our previous Merit Review grants (Seiple, Szlyk et al., 2005, 2011). The PAECT platform will be designed to allow patients to easily run the training exercises in their homes and to practice at their convenience. The PAECT will employ an executive component that will keep track of the exercises that are practiced and record performance. Each time a subject opens the platform, it will choose the exercise for that subject based upon previous training and performance.
Study: NCT02141425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP015K
Description: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP015K
Description: oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP015K
Description: oral

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral
Study: NCT04260867

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Essential Oil
Description: Those randomized to the treatment group will have containers filled with the essential oil of their choice.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No Essential Oil
Description: Those randomized to the control group will then be given empty single-use handheld aromatherapy containers containing no essential oil.
Study: NCT02385253

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational training program
Description: The educational training program (intervention) consists of four sequential phases:~1. Knowledge Acquisition~2. Skills Assessment~3. Deliberate Practice~4. Clinical Proficiency
Study: NCT01737489

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LACE
Description: commercially available LACE program which is administered by computer as daily lessons. The participants will do this program for one month
Study: NCT04574180

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dental Crown
Description: Pediatric size dental crown; restore damaged tooth to its normal shape, size, and function.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dental Crown
Description: Pediatric size dental crown; restore damaged tooth to its normal shape, size, and function.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dental Crown
Description: Pediatric size dental crown; restore damaged tooth to its normal shape, size, and function.
Study: NCT00695500

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets, 0 mg per day for 3 weeks
Study: NCT00976287

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hepatic artery infusion
Description: Patients with liver cirrhosis were randomly separated into two groups. Autologous MSCs were infused to patients using interventional method via hepatic artery for One group. The catheter was inserted to proper hepatic artery. After the catheter placed at proper hepatic artery was confirmed by angiography, autologous bone marrow MSCs were infused slowly for 20-30 minutes. The control group accepted conserved therapy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conserved Therapy
Description: Conserved Therapy
Study: NCT00237666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Description: Ziprasidone 20-60 mg BID, taken orally.
Study: NCT03995745

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication adherence and financial incentives
Description: Provision of wireless devices and financial incentives to motivate medication adherence among HIV-positive adults who have not reached viral suppression.
Study: NCT02236273

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional text message reminder
Description: Receipt of conventional text message notifying when due for next dose

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced text message reminders
Description: Receipt of enhanced text messages notifying when due for next dose coupled with educational information
Study: NCT01643265

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey Milk Protein
Description: 20 grams of Whey Milk Protein

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bovine Albumin Concentrate
Description: 20 grams of Bovine Albumin Concentrate
Study: NCT02435459

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: No lining
Description: No lining material placed under amalgam dental restorations

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Hydroxide cement
Description: placement of lining material under amalgam dental restorations

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RMGI cement
Description: placement of lining material under amalgam dental restorations

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resin Bonding Agent
Description: placement of lining material under amalgam dental restorations
Study: NCT00659386

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin therapy
Description: Patients received total dose of 2 g/kg of immune globulin administered as 0.5 g/kg IV over a period of 6 hours on each of 3 consecutive days.
Study: NCT03780530

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: subcuticular suturing
Description: Those undergoing Subcuticular suturing of perineal skin using 910 polyglactin vicryl No 2/0 (EGYCRYL®).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical glue
Description: Those undergoing perineal skin closure using adhesive glue n-butyl-2-cyanoacrylate (Histoacryl®).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: adhesive steri-strip tape
Description: Those undergoing closure of perineal skin via Adhesive surgical water-resistant tape application. (3M® Transpore™ Surgical Tapes).
Study: NCT01118403

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sultamicillin
Description: Ampoules per 1.5 grams, three grams intravenously every 6 hours for 4 doses diluted in physiologic Sodium Chloride Solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sultamicillin
Description: Ampoules per 1.5 grams, three grams intravenously every 6 hours for 4 doses diluted in physiologic Sodium Chloride Solution
Study: NCT04301934

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mona Lisa Touch
Description: Fractional CO2 LASER

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conjugated estrogen
Description: Current standard treatment for recurrent UTIs in postmenopausal women

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estradiol
Description: Current standard treatment for recurrent UTIs in postmenopausal women
Study: NCT02596568

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Description: tDCS is a type of brain stimulation that uses low current applied directly over the scalp to increase, or decrease cortical activity under the stimulating electrodes. tDCS applied bi-frontally using Chattanooga Ionto™ Iontophoresis System - Phoresor. A square wave will be delivered at 0.75 Hz for five blocks of five minutes each with one minute inter-train interval. Stimulation will be applied following 8 epochs of consecutive stage 2 or deeper sleep.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: tDCS device connected and tested, but not turned on during the night. This has been found to be an effective sham in other studies using this technique.
Study: NCT04345900

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plinabulin
Description: a synthetic, low molecular weight, new chemical entity that belongs to the diketopiperazine class of compounds. Plinabulin is intended for intravenous (IV) infusion and is diluted in D5W and administered for 30 minutes (± 5 minutes).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plinabulin
Description: a synthetic, low molecular weight, new chemical entity that belongs to the diketopiperazine class of compounds. Plinabulin is intended for intravenous (IV) infusion and is diluted in D5W and administered for 30 minutes (± 5 minutes).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plinabulin
Description: a synthetic, low molecular weight, new chemical entity that belongs to the diketopiperazine class of compounds. Plinabulin is intended for intravenous (IV) infusion and is diluted in D5W and administered for 30 minutes (± 5 minutes).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pegfilgrastim
Description: PEGFILGRASTIM is a long-acting granulocyte colony-stimulating factor that stimulates the growth of neutrophils, to reduce the incidence of fever and infection in patients with certain types of cancer who are receiving chemotherapy that affects the bone marrow.
Study: NCT03641781

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: isometric strength training and isokinetic strength training
Description: Isokinetic strength program included strength training at 5 different velocities from slow to fast. Participants were trained on speed of 30°/sec, 90°/sec, 150°/sec, 210°/sec and 270°/sec. Flexion and extension movements were completed with 5 repetitions at each speed.~Participants of isometric strength training group performed isometric contractions at 30°, 45° and 60° of knee flexion with five repetitions at each angle for both hamstring and quadriceps.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: isometric strength training and isokinetic strength training
Description: Isokinetic strength program included strength training at 5 different velocities from slow to fast. Participants were trained on speed of 30°/sec, 90°/sec, 150°/sec, 210°/sec and 270°/sec. Flexion and extension movements were completed with 5 repetitions at each speed.~Participants of isometric strength training group performed isometric contractions at 30°, 45° and 60° of knee flexion with five repetitions at each angle for both hamstring and quadriceps.
Study: NCT01141244

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temsirolimus
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide
Description: Given orally
Study: NCT03210571

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eyeWatch system
Description: The eyeWatch device is composed of an AGDD, a control unit and a draining plate
Study: NCT01141244

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: irinotecan hydrochloride
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT03096743

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MR elastography
Description: MR elastography image acquisition will be conducted on the Compact 3T MRI scanner using a modified single-shot spin-echo echo-planar imaging pulse sequence.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MR elastography
Description: MR elastography image acquisition will be conducted on the Compact 3T MRI scanner using a modified single-shot spin-echo echo-planar imaging pulse sequence.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI structural brain imaging
Description: MRI structural brain imaging will be done on the Compact 3T MRI at the same time as MR elastography.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI structural brain imaging
Description: MRI structural brain imaging will be done on the Compact 3T MRI at the same time as MR elastography.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar puncture
Description: All patients with papilledema will get lumbar punctures with opening pressure as part of their work-up for papilledema. A small number of patients without increased intracranial pressure will receive a lumbar puncture.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optical Coherence Tomography (OCT) imaging
Description: Optical Coherence Tomography (OCT) imaging will measure the peripapillary retinal nerve fiber layer (RNFL) thickness measurements The images with enhanced depth imaging will be obtained to measure the Bruch's membrane orientation.
Study: NCT00135096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin glulisine
Description: PREMEAL ARM: Subjects randomized to this arm will receive Apidra administered three times per day 0-15 min before the three main meals; metformin (if applicable); and Lantus qd for 52 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin glargine
Description: POSTMEAL ARM: Subjects randomized to this arm will receive Apidra administered three times per day immediately after a meal (20 min after the start of a meal); metformin (if applicable); and Lantus qd for 52 weeks.
Study: NCT02164825

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine perineural injection
Description: Ultrasound guided single-shot femoral nerve block

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: morphine and ropivacaine
Description: Continuous epidural analgesic perfusion Epidural perfusion with morphine and ropivacaine.
Study: NCT02654743

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sulforaphane
Description: Children with ASD will receive Sulforaphane in this study
Study: NCT04464629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextenza
Description: Intracanalicular sustained release dexamethasone insert 0.4 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone Acetate
Description: Topical Prednisolone acetate 1% ophthalmic suspension
Study: NCT03909841

Intervention type: BEHAVIORAL
Intervention: Cambridge Neuropsychological Test Automated Battery (CANTAB)
Description: Cognition using Cambridge Neuropsychological Test Automated Battery (CANTAB)

Intervention type: BEHAVIORAL
Intervention: Cambridge Neuropsychological Test Automated Battery (CANTAB)
Description: Cognition using Cambridge Neuropsychological Test Automated Battery (CANTAB)

Intervention type: BEHAVIORAL
Intervention: Cambridge Neuropsychological Test Automated Battery (CANTAB)
Description: Cognition using Cambridge Neuropsychological Test Automated Battery (CANTAB)
Study: NCT03096743

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optical Coherence Tomography (OCT) imaging
Description: Optical Coherence Tomography (OCT) imaging will measure the peripapillary retinal nerve fiber layer (RNFL) thickness measurements The images with enhanced depth imaging will be obtained to measure the Bruch's membrane orientation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optic nerve B-scan ultrasound
Description: Ultrasound will be used to measure the optic nerve sheath diameter 3 mm posterior to the posterior scleral surface.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Optic nerve B-scan ultrasound
Description: Ultrasound will be used to measure the optic nerve sheath diameter 3 mm posterior to the posterior scleral surface.
Study: NCT03821870

Intervention type: DIAGNOSTIC_TEST
Intervention: Inditreat
Description: Tumoroid formation and drug sensitivity analysis

Intervention type: DRUG
Intervention: Experimental drug
Description: Second line treatment based on drug sensitivity analysis
Study: NCT03804502

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TearCare
Description: The TearCare System warms the eyelids to melt the meibum by applying heat to the external surface of the eyelids for 15 minutes. Following completion of the thermal portion of the procedure, the clinician performs manual expression of each of the eyelids.
Study: NCT02322463

Intervention type: DRUG
Intervention: Arab children
Description: Treatment with Oxycodone
Study: NCT01737489

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NOOK
Description: will use an electronic reader (Barnes and Noble - NOOK device) to do speech tracking.will do this activity for approximately one hour per day for five days out of seven for a total of four weeks. The speech tracking activity will involve reading approximately two books within the one month time frame. The participants will listen to the book while reading an unabridged book in printed form.
Study: NCT01571804

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: to receive two identical placebo capsules 1 hr before surgery
Study: NCT00944619

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed loop
Description: Subcutaneous delivery of Novorapid insulin, dose calculated by control algorithm, based on continuous glucose sensor readings

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Conventional insulin pump delivery
Description: Subcutaneous delivery of Novorapid insulin according to usual pump regime
Study: NCT04605003

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Novel rig-S
Description: A new device created to hold the high level disinfectant and automatically indicate when sterilisation process has been completed

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Novel rig-S
Description: A new device created to hold the high level disinfectant and automatically indicate when sterilisation process has been completed

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Autoclave machine
Description: The gold standard device to clean all medical instruments

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Autoclave machine
Description: The gold standard device to clean all medical instruments
Study: NCT02763371

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary: high GI lunch
Description: High GI: High-GI rice lunch ad libitum on test day 1 and low GI-rice lunch on test day 2. Water at libitum was constantly available on both days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary: low GI lunch
Description: Low-GI: Low GI-rice lunch ad libitum on test day 1 and high GI-rice lunch on test day 2. Water at libitum was constantly available on both days.
Study: NCT01928706

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Denture liner Mucopren Soft; Group 1
Description: Complete denture wearers had their existing mandibular dentures relined with a soft silicone-based denture liner (Mucopren Soft; Group 1; n=22)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Denture liner Kooliner; Group 2
Description: Complete denture wearers had their existing mandibular dentures relined with a hard acrylic resin based denture liner (Kooliner; Group 2;n=22) with chairside procedures.
Study: NCT01094418

Intervention type: OTHER
Intervention: Nerve conduction studies ( NCS) of the peripheral nerves
Description: Standard NCS of the sural, superficial peroneal sensory nerves, peroneal, tibial motor nerves, radial and median sensory nerves, median motor nerves, F-wave studies of the Tibial and median nerves.~NCS of the distal sensory nerves; dorsal sural Medial dorsal cutaneous and medial plantar nerves.

Intervention type: OTHER
Intervention: Nerve conduction studies ( NCS) of the peripheral nerves
Description: Standard NCS of the sural, superficial peroneal sensory nerves, peroneal, tibial motor nerves, radial and median sensory nerves, median motor nerves, F-wave studies of the Tibial and median nerves.~NCS of the distal sensory nerves; dorsal sural Medial dorsal cutaneous and medial plantar nerves.

Intervention type: OTHER
Intervention: Nerve conduction studies ( NCS) of the peripheral nerves
Description: Standard NCS of the sural, superficial peroneal sensory nerves, peroneal, tibial motor nerves, radial and median sensory nerves, median motor nerves, F-wave studies of the Tibial and median nerves.~NCS of the distal sensory nerves; dorsal sural Medial dorsal cutaneous and medial plantar nerves.
Study: NCT04301908

Intervention type: DRUG
Intervention: interferon
Description: Antiviral therapy for patients with chronic hepatitis B and cirrhosis. Antiviral therapies included interferon and / or nucleoside (acid) analogs, and patients who were continuously treated for more than 6 months were included in the study.
Study: NCT03716414

Intervention type: PROCEDURE
Intervention: SLN mapping
Description: Intra-operative SLN mapping with indocyanine green: Intracervical injection will be performed by the surgeon. Sub-mucous injections will be performed with 50% diluted dye at 3 and 9 o'clock positions. 1ml injection contained infracyanine green will be injected deeply into the stroma of the cervix (1cm-depth), and Arms Assigned Interventions another 1ml will be injected superficially (2mm-depth).~The time between the injection and the search for SLN must be as soon as possible.
Study: NCT02113189

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking program with ankle brace
Description: Walking program will include instructions on walking activities at home such as time of walking. Walking will be done with the bilateral ankle braces on.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized walking program
Description: Walking program will include instructions on walking activities at home such as time of walking

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking program with custom braces.
Description: Walking program will include instructions on walking activities at home such as time of walking. Walking will be done with custom-fabricated ankle braces on.
Study: NCT02336035

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Volar plate
Description: Flexor carpi radialis (FCR)-approach. Standard surgical procedure with a volar locking plate